*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ ImmunoGen/NNP Inc./NNP ]
said/VBD 
[ it/PRP ]
filed/VBD with/IN 
[ the/DT Securities/NNPS ]
and/CC 
[ Exchange/NNP Commission/NNP ]

[ a/DT registration/NN statement/NN ]
proposing/VBG 
[ an/DT initial/JJ public/JJ offering/NN ]
of/IN 
[ 1.5/CD million/CD common/JJ shares/NNS ]
./. 

======================================

[ The/DT offering/NN ]
will/MD be/VB 
[ underwritten/NN ]
by/IN 
[ a/DT syndicate/NN ]
represented/VBN by/IN 
[ PaineWebber/NNP Inc./NNP ]
and/CC 
[ Hambrecht/NNP ]
&/CC 
[ Quist/NNP Inc/NNP ]
./. 

[ Proceeds/NNS ]
are/VBP expected/VBN to/TO be/VB used/VBN for/IN 
[ expenditures/NNS ]
relating/VBG to/TO 
[ product/NN research/NN ]
and/CC 
[ development/NN ]
,/, 
[ preclinical/JJ ]
and/CC 
[ clinical/JJ testing/NN programs/NNS ]
,/, 
[ expansion/NN ]
of/IN 
[ manufacturing/NN capacity/NN ]
,/, working/VBG 
[ capital/NN ]
and/CC 
[ general/JJ corporate/JJ purposes/NNS ]
./. 

======================================

[ ImmunoGen/NNP ]
develops/VBZ 
[ pharmaceuticals/NNS ]
for/IN 
[ cancer/NN treatment/NN ]
./. 
